Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial

An antiangiogenic approach is especially suitable for the treatment of malignant gliomas. Recently, two large clinical trials in newly diagnosed glioblastoma (the Avastin in Glioblastoma study and Radiation Therapy Oncology Group 0825 study) showed a 3- to 4-month prolongation of progression-free su...

Descripción completa

Detalles Bibliográficos
Autores principales: Takano, Shingo, Ishikawa, Eiichi, Nakai, Kei, Matsuda, Masahide, Masumoto, Tomohiko, Yamamoto, Tetsuya, Matsumura, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161529/
https://www.ncbi.nlm.nih.gov/pubmed/25228814
http://dx.doi.org/10.2147/OTT.S67621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161529/
https://www.ncbi.nlm.nih.gov/pubmed/25228814
http://dx.doi.org/10.2147/OTT.S67621

Ejemplares similares